SUNScholar
metadata only
QT interval prolongation with one or more QT-prolonging agents used as part of a multidrug regimen for rifampicin- resistant tuberculosis treatment : findings from two pediatric studies
CITATION: Ali, A.M., Radtke, K.K., Hesseling, A.C., Winckler, J., Schaaf, H.S., Draper, H.R., Solans, B.P., van der Laan, L., Hughes, J., Fourie, B. and Nielsen, J., 2023. QT interval prolongation with one or more QT-prolonging agents used as part of a multidrug regimen for rifampicin-resistant tube
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Optimization of MDR-TB Treatment Regimen Based on the Molecular Drug Susceptibility Results of Pyrazinamide#1463444
- Shortening Treatment by Advancing Novel Drugs#1153608
- PA-824-CL-007: Phase IIa Evaluation of Early Bactericidal Activity in Pulmonary Tuberculosis#861002
- A Phase III Study of Oral Sudapyridine (WX-081) Tablets in Rifampicin-Resistant Pulmonary Tuberculosis Patients#1409362
- Pharmacokinetic Study to Evaluate Anti-mycobacterial Activity of TMC207 in Combination With Background Regimen (BR) of Multidrug Resistant Tuberculosis (MDR-TB) Medications for Treatment of Children/Adolescents With Pulmonary MDR-TB#889808
Record · ID 1539234
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive